NORTHWESTERN UNIVERSITY
Understanding the Behavior of Novel IL13Ralpha2-directed T cell Engager for GBM
Understanding the Behavior of Novel IL13Ralpha2-directed T cell Engager for GBM is a funding opportunity from NORTHWESTERN UNIVERSITY, up to 348526, closing August 31, 2026.
Aug 31, 2026
(31d left)Overview
Glioblastoma (GBM) remains incurable cancer with a dismal survival rate despite aggressive multimodal therapy that can include surgery, radiation, chemotherapy, and tumor-treating fields. The failure to improve outcome in GBM patients underscores an urgent need to develop new targeted therapies. Bi-specific T cell…